SCHEMBL29650244

SCHEMBL29650244

CC(C)(C)OC(=O)n1ccc2ncc(SCc3ccccc3)cc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2C P28335 1/20 0.42
▸ SLC6A4 P31645 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ GAA P10253 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ PRMT5 O14744 1/20 0.39
▸ GCK P35557 1/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.37
▸ SCN9A Q15858 1/20 0.36
▸ MET P08581 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ MAPT P10636 1/20 0.35
▸ GRIN2B Q13224 1/20 0.35
▸ OPRD1 P41143 1/20 0.35
▸ OPRK1 P41145 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ IDO1 P14902 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21064287 1.00 HTR2C (0.42) HTR2CSLC6A4KDM4EALDH1A1GAA
SCHEMBL25702072 0.89 APP (0.39) KDM4EALDH1A1GAASMN1; SMN2MAPT
SCHEMBL21353203 0.84 PTGDR2 (0.39) KDM4EALDH1A1SMN1; SMN2GCKSCN9A
SCHEMBL30199691 0.82 TSHR (0.41) KDM4EALDH1A1SMN1; SMN2GCKNPSR1
SCHEMBL29248231 0.76 PTGDR2 (0.43) KDM4EALDH1A1GAASMN1; SMN2MAPT
SCHEMBL25909811 0.74 HSP90AA1 (0.41) KDM4EALDH1A1METGRIN2BMEN1
SCHEMBL20483115 0.74 KDM4E (0.39) KDM4EALDH1A1METGRIN2B
SCHEMBL25229548 0.73 ALDH1A1 (0.41) KDM4EALDH1A1METMAPTKMT2A
SCHEMBL31194316 0.73 MET (0.43) KDM4EALDH1A1METGRIN2B
SCHEMBL31194282 0.72 GABRG2 (0.39) KDM4EALDH1A1METGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111699189-B Modulators of beta-3 adrenergic receptors useful for treating or preventing heart failure and disorders associated therewith 艾尼纳制药公司 2025-02-18 — — CN disclosed
CN-109563103-B Modulators of beta-3 adrenergic receptors for the treatment or prevention of disorders related thereto 艾尼纳制药公司 2022-05-27 — — CN disclosed
Send feedback